46 results on '"Bini, Marta"'
Search Results
2. High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors
3. Avancées thérapeutiques dans la prise en charge des tumeurs rares malignes ovariennes
4. Bridging borders with care: a journey in providing oncology treatment to foreign women at a tertiary center in Italy
5. Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology
6. Update on new treatments for rare ovarian tumours
7. Uterine serous carcinoma
8. The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy
9. Updates in the Management of Foreign Bodies of the Gastrointestinal Tract
10. #611 Correlation between KELIM and CRS score in women with advanced ovarian cancer treated with neoadjuvant chemotherapy and interval debulking surgery
11. #269 Real-life experience of pazopanib in uterine leyomiosarcoma (U-LMS) in a tertiary oncologic center in Italy: evaluation of safety and effectiveness
12. A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy: Effectiveness and Safety.
13. The Revolution of Immunotherapy in Gynecological Cancers: The Lazarus Effect in Endometrial Cancer
14. Empowering gynecologic oncologists: navigating new drugs and emerging toxicities
15. ESR1 Rearrangement as a Diagnostic and Predictive Biomarker in Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Report of Four Cases
16. Endometrial carcinosarcoma
17. Update on new treatments for rare ovarian tumours
18. Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world
19. Real-World Data on Newly Diagnosed BRCA-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database
20. Platinum sensitivity in patients with IDH1/2 mutated vs wild‐type intrahepatic cholangiocarcinoma: A propensity score‐based study
21. Abstract 1269: Negative ultra-selection of patients with RAS/BRAF wild-type (wt), microsatellite stable (MSS) metastatic colorectal cancer (mCRC) receiving anti-EGFR-based therapy: The PRESSING2 study
22. MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
23. Genomic determinants and clinical relevance of cancer-associated thrombosis in biliary tract cancers.
24. Adaptive response analysis of colorectal cancer cells to low-dose oxaliplatin as a tool to deciphering mechanisms of synergistic drug interaction.
25. BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer
26. Clear cell carcinoma of the endometrium
27. Blood Bacterial DNA Load and Profiling Differ in Colorectal Cancer Patients Compared to Tumor-Free Controls
28. BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer
29. Nanodispersions of TiO2 in Water for Removing Acrylic Films Used in Conservation
30. Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma
31. A Modified Boston Bowel Preparation Scale After Colorectal Surgery
32. Blood bacterial DNA, intestinal adenoma and colorectal cancer
33. Abstract 1669: Immunometabolism of circulating neutrophils in hyperprogressive disease (HPD) upon first-line PD-1/PD-L1 inhibitors (ICI) alone or in combination with platinum-based chemotherapy (PCT) in non-small cell lung cancer (NSCLC) patients (pts)
34. Abstract PO-065: Artificial intelligence to improve selection for NSCLC patients treated with immunotherapy
35. COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study
36. Risk of disease progression (PD) following discontinuation of BRAF±MEK targeted therapies for reasons other than PD in patients (pts) with metastatic or unresectable melanoma.
37. Combined use of albumin and neutrophil-to-lymphocyte ratio as new prognostic and predictive factor in patients with poorly differentiated neuroendocrine carcinomas.
38. Demethylating agents to upregulate HLAs and antigen presenting machinery (APM) related genes in HER2+ breast cancer (BC) cell lines.
39. Update on Management of Caustic and Foreign Body Ingestion in Children
40. Management of patients with gastroesophageal reflux disease: a long-term, follow-up study
41. Endoscopic Treatment of Anastomotic Biliary Stenosis in Patients With Orthotopic Liver Transplantation
42. Nanodispersions of TiO 2 in Water for Removing Acrylic Films Used in Conservation.
43. Endoscopic Treatment of Anastomotic Biliary Stenosis in Patients With Orthotopic Liver Transplantation
44. A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy: Effectiveness and Safety.
45. [Treatments for rare ovarian tumors: What's new?]
46. Endometrial carcinosarcoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.